Derivatives of the IL-2 receptor gamma chain, their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S021300, C424S146100, C530S350000

Reexamination Certificate

active

08048847

ABSTRACT:
This invention relates to the use of the IL-2 common gamma (cγc) and related molecules for the modulation of signal activities controlled by NIK, and some new such molecules.

REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5510259 (1996-04-01), Sugamura et al.
patent: 5844073 (1998-12-01), Rothe et al.
patent: 6610658 (2003-08-01), Findeis et al.
patent: 7070972 (2006-07-01), O'Shea et al.
patent: 0578932 (1994-01-01), None
patent: 07-133298 (1995-05-01), None
Malinin et al., Nature. Feb. 6, 1997;385(6616):540-4, Abstract Only.
Song et al., PNAS USA Sep. 2, 1997;94(18):9792-6, Abstract Only.
Dejardin et al., Immunity. Oct. 2002;17(4):525-35, Abstract Only.
Ramakrishnan et al., Immunity. Oct. 2004;21(4):477-89, Abstract Only.
O'Connell et al., (J Mol Evol., 2005; 61:608-619).
Benjamin et al., “A Plasticity Window for Blood Vessel Remodelling is Defined by Pericyte Coverage of the Preformed Endothelial Network and is Regulated by PDGF-B and VEGF,” 1998, Development 125:1591-1598.
Bork et al., “Go Hunting in Sequence Databases but Watch Out for the Traps,” Trends in Genetics. 1996; 12:425-427.
Bork., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle,” Genome Research. 2000; 10:398-400.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,” Science. 1990; 247:1306-1310.
Brenner, S. E., “Errors in Genome Annotation,” Trends in Genetics. 1999; 15:132-133.
Dejardin et al., “The Lymphotoxin-beta Receptor Different Patterns of Gene Expression Via Two NF-kappaB Pathways,”Immunity. Oct. 2002;17(4):525-35, Abstract Only.
Doerks et al., “Protein Annotation: Detective Work for Function Prediction,” Trends in Genetics. 1998; 14:248-250.
Malinin et al., “MAP3K-related Kinase Involved in NF-kappaB Induction by TNF, CD95 and IL-1,” Nature. Feb. 6, 1997;385(6616):540-4, Abstract Only.
Massague, J., “The TGF-β Family of Growth and Differentiation Factors,” Cell. 1987; 49:437-8.
O'Connell et al., “Gamma Chain Receptor Interleukins: Evidence for Positive Selection Driving the Evolution of Cell-to-Cell-Communications in the Mammalian Immune System,” J Mol Evol., 2005; 61 :608-619.
Pilbeam et al., “Comparison of the Effects of Various Lengths of Synthetic human Parathyroid Hormone-Related Peptide (hPTHrp) of Malignancy on Bone Resorption and Formation in Organ Culture,” Bone. 1993; 14:717-720.
Ramakrishnan et al., “Receptor-Specific Signaling for Both the Alternative and the Canonical NF-kappaB Activation Pathways by NF-kappaB-inducing Kinase,” Immunity. Oct. 2004;21 (4):477-89, Abstract Only.
Skolnick et al., “From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era,” Trends in Biotech. 2000; 18:34-39.
Smith et al., “The Challenges of Genome Sequence Annotation or The Devil is in Details,” Nature Biotechnology. 1997; 15:1222-122b.
Song et al.,“Tumor Necrosis Factor (TNF)-Mediated Kinase Cascades: Bifurcation of Nuclear Factor-kappaB and C-jun N-Terminal Kinase (JNK/SAPK) Pathways at TNF Receptor-Associated Factor 2,” PNAS USA Sep. 2, 1997;94 (18):9792-6, Abstract Only.
Vukicevic et al., “Induction of Nephrogenic Mesenchyme by Osteogenic Protein 1 (Bone Morphogenetic Protein 7),” PNAS USA.1996; 93:9021-9026.
Wells, J. A. “Additivity of Mutational Effects in Proteins,” Biochemistry. 1990; 29:8509-8517.
Accession P31785, “RecName: Full=Cytokine receptor common subunit gamma; AltName: Full-Interleukin-2 receptor subunit gamma; Short=IL-2 receptor subunit gamma; Short-IL-2R subunit gamma; Short-IL-2RG; AltName: Full-p64; AltName: CD—antigen=CD132; Flags: Precursor”, pp. 1-9, May 26, 2001.
Adang, et al., Abstract Only, “The contribution of combinatorial chemistry to lead generation: an interim analysis”,Curr. Med. Chem., vol. 8(9), pp. 985-998, Jul. 2001.
Baldwin, Albert S. Jr., “The NF-κB and IκB Proteins: New Discoveries and Insights”,Annu. Rev. Immunol., vol. 14, pp. 649-683, 1996.
Fields, et al., Abstract Only, “A novel genetic system to detect protein-protein interactions”,Nature, vol. 340, pp. 245-246, 1989.
Ghosh, et al., Abstract Only, “NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses”,Annu. Rev. Immunol., vol. 16, pp. 225-260, 1998.
Karin, et al., Abstract Only, “Phosphorylation meets ubiquitination: the control of NF-[Kappa]B activity”,Annu. Rev. Immunol., vol. 18, pp. 621-663, 2000.
Leonard, et al., Abstract Only, “Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development”,Immunol. Rev., vol. 148, pp. 97-114, Dec. 1995.
Lin, et al., “The Proto-OncogeneCotKinase Participates in CD3/CD28 Induction of NF-kappaB Acting through the NF-kappaB-Inducing Kinase and IkappaB Kinases”,Immunity, vol. 10, pp. 271-280, Feb. 1999.
Malinin, et al., “MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”,Nature, vol. 385, pp. 54-544, Feb. 1997.
Mercuric, et al., “Multiple signals converging on NF-kappaB”,Curr Opin. Cell Biol, vol. 11, pp. 226-232, 1999.
Miyawaki, et al., Abstract Only, “A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice”,Eur. J Immunol, vol. 24, pp. 429-434, 1994.
Noguchi, et al., Abstract Only, “Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans”,Cell, vol. 73, pp. 147-157, 1993.
Regnier, et al., “Identification and Characterization of an IkappaB Kinase”,Cell, vol. 90, pp. 373-383, Jul. 1997.
Rothe, et al., Abstract Only, “A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor”,Cell, vol. 78, pp. 681-692, Aug. 1994.
Senftleben, et al., “Activation by IKKalpha of a Second, Evolutionary Conserved, NF-kappaB Signaling Pathway”,Science, vol. 293, pp. 1495-1499, Aug. 2001.
Shinkura, et al., Abstract Only, “Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase”,Nat. Genet., vol. 22, pp. 74-77, May 1999.
Smith, G.P., Abstract Only, “Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface”,Science, vol. 228, pp. 1315-1317, Jun. 1985.
Takeshita, at al., “Cloning of the gamma chain of the human IL-2 receptor”,Science, vol. 257, pp. 379-382, Jul. 1992.
Xiao, et al., “NF-kappaB-Inducing Kinase Regulates the Processing of NF-kappaB2 p100”,Mol Cell, vol. 7, pp. 401-409, Feb. 2001.
Yin, et al., “Defective Lymphotoxin-beta Receptor-Induced NF-kappaB Transcriptional Activity in NIK-Deficient Mice”,Science, vol. 291, pp. 2162-2165, Mar. 2001.
“Sequence 4 from patent US 5510259,” GenBank: AAB11694.1 (1996).
“Sequence 7 from patent US 5510259,” GenBank: AAB11695.1 (1996).
Akiba et al., “CD27, a Member of the Tumor Necrosis Factor Receptor Superfamily, Activates NF-kB and Stress-activated Protein Kinase/c-Jun N-terminal Kinase via TRAF2, TRAF5, and NF-kB-inducing Kinase*”, The Journal of Biological Chemistry, May 22, 1998, vol. 273, No. 21, pp. 13353-13358.
Canicio et al., “Nuclear Factor kB-inducing Kinase and IkB Kinase—a Signal Skeletal Muscle Cell Differentiation”, The Journal of Biological Chemistry, Jun. 8, 2001, vol. 276, No. 23, pp. 20228-20233.
Darnay et al., “Activation of NF-kB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-kB-inducing Kinase”, The Journal of Biological Chemistry, Mar. 19, 1999, vol. 274, No. 12, pp. 7724

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives of the IL-2 receptor gamma chain, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of the IL-2 receptor gamma chain, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of the IL-2 receptor gamma chain, their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4256993

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.